Related references
Note: Only part of the references are listed.Renal decline in patients with non-valvular atrial fibrillation treated with rivaroxaban or warfarin: A population-based study from the United Kingdom
Antonio Gonzalez Perez et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2022)
2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary *
Tze-Fan Chao et al.
THROMBOSIS AND HAEMOSTASIS (2022)
Adherence to the 'Atrial Fibrillation Better Care' Pathway in Patients with Atrial Fibrillation: Impact on Clinical Outcomes-A Systematic Review and Meta-Analysis of 285,000 Patients
Giulio Francesco Romiti et al.
THROMBOSIS AND HAEMOSTASIS (2022)
Incidence and Risk Factors for Residual Adverse Events Despite Anticoagulation in Atrial Fibrillation: Results From Phase II/III of the GLORIA-AF Registry
Wern Yew Ding et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)
The impact on renal function after long-term use of anticoagulants in atrial fibrillation patients
Wei-Chieh Lee et al.
THROMBOSIS JOURNAL (2021)
Changes in glomerular filtration rate and outcomes in patients with atrial fibrillation
Laurent Fauchier et al.
AMERICAN HEART JOURNAL (2018)
Statistical primer: propensity score matching and its alternatives
Umberto Benedetto et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2018)
The risk of acute kidney injury in Asians treated with apixaban, rivaroxaban, dabigatran, or warfarin for non-valvular atrial fibrillation: A nationwide cohort study in Taiwan
Yi-Hsin Chan et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Impact of Renal Function on Outcomes With Edoxaban in Real-World Patients With Atrial Fibrillation A Nationwide Cohort Study
Hee Tae Yu et al.
STROKE (2018)
Renal Outcomes in Anticoagulated Patients With Atrial Fibrillation
Xiaoxi Yao et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
The ABC pathway: an integrated approach to improve AF management
Gregory Y. H. Lip
NATURE REVIEWS CARDIOLOGY (2017)
Causes of Death and Influencing Factors in Patients with Atrial Fibrillation
Laurent Fauchier et al.
AMERICAN JOURNAL OF MEDICINE (2016)
On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin Insights From ROCKET AF
Christopher B. Fordyce et al.
CIRCULATION (2016)
Renal Function in Atrial Fibrillation A Multifaceted Dilemma
Ziad Hijazi et al.
CIRCULATION (2016)
Acute Kidney Injury in Asians With Atrial Fibrillation Treated With Dabigatran or Warfarin
Yi-Hsin Chan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation in Relation to Renal Function Over Time Insights From the ARISTOTLE Randomized Clinical Trial
Ziad Hijazi et al.
JAMA CARDIOLOGY (2016)
Changes in Renal Function in Patients With Atrial Fibrillation An Analysis From the RE-LY Trial
Michael Boehm et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
GFR Decline as an End Point for Clinical Trials in CKD: A Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration
Andrew S. Levey et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease
Erica M. Sparkenbaugh et al.
BLOOD (2014)
The Occurrence of Warfarin-Related Nephropathy and Effects on Renal and Patient Outcomes in Korean Patients
Jung Nam An et al.
PLOS ONE (2013)
Vascular calcification: The price to pay for anticoagulation therapy with vitamin K-antagonists
Martijn L. L. Chatrou et al.
BLOOD REVIEWS (2012)
Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation - The J-ROCKET AF Study
Masatsugu Hori et al.
CIRCULATION JOURNAL (2012)
Vitamin K-Antagonists Accelerate Atherosclerotic Calcification and Induce a Vulnerable Plaque Phenotype
Leon J. Schurgers et al.
PLOS ONE (2012)
The Effects of Direct Thrombin Inhibition with Dabigatran on Plaque Formation and Endothelial Function in Apolipoprotein E-Deficient Mice
Illkyu-O. Lee et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate
Sergey V. Brodsky et al.
KIDNEY INTERNATIONAL (2011)
An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
Peter C. Austin
MULTIVARIATE BEHAVIORAL RESEARCH (2011)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Use of Stabilized Inverse Propensity Scores as Weights to Directly Estimate Relative Risk and Its Confidence Intervals
Stanley Xu et al.
VALUE IN HEALTH (2010)
Acute Kidney Injury During Warfarin Therapy Associated With Obstructive Tubular Red Blood Cell Casts: A Report of 9 Cases
Sergey V. Brodsky et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Variable selection for propensity score models
M. Alan Brookhart et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2006)
Share Paper
